Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending June 9
Bayer, Komodo Health, Circana, Lovesac, Harvard University, Kate Farms, Chemours, Marathon Digital Holdings
By
Lauren Muskett
| June 9, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending June 9
Bayer, Komodo Health, Circana, Lovesac, Harvard University, Kate Farms, Chemours, Marathon Digital Holdings
By
Lauren Muskett
| June 9, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Teva Pharmaceutical Industries
Strategy
Teva to Buy Allergan’s Generic Drug Unit for $40.5B
If the deal is approved, Teva says the combined company would have revenue of about $26 billion and EBITDA of $9.5 billion in 2016.
By
Katie Kuehner-Hebert
| July 27, 2015
Read More
